HMGCR and migraine disorder: The MR study by Bi et al. supported these findings by revealing that HMGCR inhibition had a significant association with a lower incidence of migraine in the FinnGen dataset (OR = 0.64, 95% CI= [0.46, 0.88]; P < 0.001) and amarginal non-signficant association in the Choquet dataset (OR = 0.78, 95% CI= [0.60, 1.01]; P = 0.06) [30].